低钾血症
- 名hypokalemia;kaliopenia
-
近年发现TMT中毒者低钾血症发生率较高。
Recently , it was found that the incidence of hypokalemia was higher .
-
CAPD患者入院时低钾血症的发生率及其临床意义
The incidence of hypokalemia associated with CAPD patients on admission and its clinical significance
-
低钾血症的原因可能为pH升高、低温及多尿。
The cause of hypopotassemia might be rising pH , hypothermia and polyuria .
-
方法对216例低钾血症患者的ECG改变、血清钾浓度以及临床资料进行回顾性分析。
Methods To retrospective analysis the ECG changes 、 serum potassium concentration and clinical information in 216 cases of hypopotassaemia patients .
-
结果CRRT治疗1~5h后,低钾血症及心律失常完全得以纠正。
Results Hypokaliemia and arhythmia were completely corrected after 1-5h of CRRT .
-
CRRT治疗老年尿毒症低钾血症并发心律失常临床观察及分析
CRRT for arhythmia caused by hypokaliemia in aged uremia
-
目的总结在重症监护病房(ICU)使用微量注射泵经中心静脉高浓度补钾纠正低钾血症的护理体会。
Objective To summarize nursing experience of microinjection pump used in high concentration potassium infusion via central vein to correct kaliopenia in ICU .
-
PICU内严重低钾血症的目标性治疗
The target treatment of severe hypokalemia in PICU
-
结论CRRT在治疗老年尿毒症患者出现低钾血症并发心律失常方面是安全、及时有效的。
Conclusion CRRT is safe , timely and effective in the treatment of arhythmia caused by hypokaliemia in aged uremia .
-
结论:临床应用地高辛,约9.81%出现中毒症状,而年龄、体重及疾病状态尤其是严重疾病伴有肾功能不全或低钾血症,对SCD有显著影响(P<0.05)。
Conclusion ; The incidence rate of digoxin toxication was 9 . 81 % . The factors influencing the SCD level include age , body weight and clinical status especially severe diseases accompanied by renal malfunction or hypopotassemia .
-
结果低钾血症的发生率为13.7%,下壁+后壁AMI的发生率最低(10.4%),明显低于下后壁+右心室、前间壁和广泛前壁心肌梗死;
Results Total incidence of hypokalemia was 13.7 % , and incidence of hypokalemia in inferior wall and posterior wall ( 10.4 % ) AMI was lower than that in inferior + posterior wall + right ventricle and anterior wall AMI .
-
结论使用微量注射泵经中心静脉高浓度补钾纠正低钾血症的方法在ICU是有效、安全的,但需要严密的临床监测和护理。
Patients ( 2.4 % ) suffered hyperkalemia . Conclusions It is effective and safe to use micro-injection pump in high concentration potassium infusion via central vein to correct kaliopenia in ICU , but rigorous clinical monitoring and nursing must be done .
-
结果23例患者静脉联合鞘内应用AmB治愈率78.3%,治疗过程中有20例发生各种不良反应,包括即刻反应、血细胞异常减少、肝肾功能损害、心脏毒性、低钾血症及静脉炎。
Results The recovering rate is 78.3 % with untoward reactions in 20 cases , including immediate reaction , reducing of blood cells , decreasing of liver and kidney functions , toxicity to heart , kaliopenia , and phlebitis .
-
本文应用门冬氨酸钾镁口服液治疗100例低钾血症患者(男性54例,女性46例,平均年龄54±16a)。
One hundred patients ( M 54 , F 46 , age 54 ± 16 a ) with hypokalemia were treated with oral potassium magnesium aspartate .
-
老年腹膜透析患者低钾血症的危险因素分析
Analysis of Risk Factors of Hypokalemia in Elder Peritoneal Dialysis Patients
-
儿童支气管哮喘发低钾血症相关因素分析
Analysis of related factors of hypokalemia children with bronchial asthma in
-
糖尿病合并低钾血症279例分析
An Analysis of 279 Cases of Hypokalemia in Patients with Diabetes
-
大剂量补钾治疗严重低钾血症13例临床疗效分析
The clinical analysis of maximus dosage K on serios hypokalemia
-
青壮年低钾血症心电图改变与临床病因关系
Relationship Between Electrocardiogram Change and Clinical Etiology of Hypokalemia in Young Adults
-
门冬氨酸钾镁口服液治疗低钾血症100例
Hypokalemia treated with oral potassium magnesium aspartate in 100 patients
-
用于治疗与本综合征相关的低钾血症。
Used to treat the hypokalemia associated with the syndrome .
-
小儿低钾血症与心电图改变的关系&附46例小儿低钾血症分析
Relation Between Infantile Hypokalemia and ECG Change in 46 Cases
-
低钾血症致房室传导阻滞的临床和心电图特点
Clinical and electrocardiographic feature of atrioventricular block caused by hypokalemia
-
最基本的特征为低钾血症和代谢性碱中毒。
The basic laboratory findings of BS was hypokalemia and metabolic alkalosis .
-
低钾血症对心脏的影响最为重要和突出。
More importantly , hypopotassaemia is very harm to heart .
-
低钾血症病人的诊断、治疗及护理进展
Progress on diagnosis , treatment , and nursing care of patients with hypokalemia
-
婴幼儿腹部大手术后低钾血症对肠功能恢复的影响
Effects of Hypokalemia on Recovery of Intestinal Function in infants After Abdominal Operation
-
目的探讨导致低钾血症发生的各种原因。
Objective To analyse various etiological factors of hypokalemia .
-
库欣综合征低钾血症与氢化可的松的关系探讨
The relationship between hypokaliemia in Cushing syndrome and cortisol
-
常规电解质检测显示低钾血症。
She had hypokalemia on a routine chemistry panel .